About Alleviant Medical
Alleviant Medical is a private company based in Austin, Texas. It has reported $148,767,388 raised in four offerings on Form D since March 2018. Its chief executive is Adam Berman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 19, 2024 | Jan 27, 2025 | $90,799,983of $91.3M target | 12 | $7.5M | EquityRule 506(b) | Form D ↗ |
| Jan 24, 2023 | Feb 7, 2023 | $43,901,405of $88.3M target | 35 | $1.2M | EquityRule 506(b) | Form D ↗ |
| May 1, 2020 | May 18, 2020amended Nov 5, 2020 | $13,000,000of $20.0M target | 18 | $722K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 19, 2017 | Mar 30, 2018 | $1,066,000of $1.5M target | 15 | $71,067 | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, four offerings | $148,767,388 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Alleviant Medical's Form D filed Jan 27, 2025.
Earlier filings also listed Kirk Nielson (director, last listed Feb 2023), Ashok Gowda (director, last listed Feb 2023), Mary Byron (director, last listed Nov 2020), Jacob Kriegel (director, last listed Nov 2020), Christopher Arevalos (executive officer and director, last listed Mar 2018), Avni Patel (executive officer and director, last listed Mar 2018) and Albertien Greijdanus (executive officer and director, last listed Mar 2018).